FdaApplication
ANDA 207101
Identifiers
- fda_app_no: ANDA207101
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | ANDA |
| approval_date | 2023-01-19 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SUMATRIPTAN SUCCINATE | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | SOLUTION;SUBCUTANEOUS |
1 product